ACBM vs MSFT: Which Stock is Better?
Side-by-side comparison of Acro Biomedical Co., Ltd. and Microsoft Corp in 2026
ACBM
Acro Biomedical Co., Ltd.
$0.02
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ACBM | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.33M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 2.0% | 14.9% | MSFT |
| Gross Margin | 17.8% | 68.8% | MSFT |
Analyze ACBM
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACBM or MSFT a better investment?
Comparing ACBM and MSFT: Acro Biomedical Co., Ltd. has a market cap of $1.33M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACBM and MSFT?
ACBM (Acro Biomedical Co., Ltd.) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACBM or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACBM or MSFT?
MSFT has higher revenue growth at 14.9% vs 2.0% for ACBM.
Which company is more profitable: ACBM or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 17.8% for ACBM.
Which is the larger company: ACBM or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $1.33M for ACBM.
Should I buy ACBM or MSFT in 2026?
Both ACBM and MSFT have investment merit. ACBM trades at $0.02 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACBM and MSFT stock?
Key differences: Market Cap ($1.33M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (2.0% vs 14.9%), Gross Margin (17.8% vs 68.8%).